Innovative Cellular Therapeutics Holdings Ltd

Overview

• HeadquartersE9¹

See how the biggest companies compare on our leaderboards

Corporate structure

Innovative Cellular Therapeutics Holdings Ltd sits at the top of its group. 2 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Stakes it holds

Innovative Cellular Therapeutics Holdings Ltd has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• Lyell Immunopharma, Inc.SCHEDULE 13G/A Nov 13, 2025 to Jun 18, 2026²